Astellas hires first chief patient exec to make 'centricity' more than a buzzword

Patient centricity can seem like just another pharma buzzword, but Astellas is working to put its money where its mouth is.

The Japanese drugmaker tapped its first "centricity"-focused exec—Anthony Yanni, recruited from Sanofi—to helm its efforts to pull in patient perspectives from drug discovery to market.